insights_auto
Why is ANTH up 35.00%?
Dive Deeperchevron_right
ANTH:OTCMKTS
Anthera Pharmaceuticals Inc
$0.00014
arrow_upward
+35.00%(+0.000035) 1D
Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANTH...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.53K
Avg. vol.
772.00
Volume
149.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.53K
Avg. vol.
772.00
Volume
149.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
News stories
From web sources and news partners
AskTraders.com
·
1 hour ago
S&P 500: Why UBS Says Investors Should ‘Stay Invested Near Record Highs’
CryptoRank
·
6 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Traders Union
·
1 hour ago
Andreas Steno Larsen: AI-related firms make up nearly half of S&P 500 market value
Hindustan Times
·
2 hours ago
Why are 54% of US stocks down 20% as the S&P 500 nears a record high? | Hindustan Times
Profile
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase, Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for the treatment of IgA nephropathy is currently in Phase 2 clinical trial. Wikipedia
About Anthera Pharmaceuticals Inc
CEO-
Employees21
Founded2004
HeadquartersHayward, California, United States
SectorBiotechnology
Websiteanthera.com